Published in TB and Outbreaks Week, December 11th, 2001
Adoxa (doxycycline), traditionally marketed by Bioglan as an adjunctive treatment of severe acne, is a broad-spectrum antibiotic member of the tetracycline class, and is approved by the FDA for the treatment of anthrax (Bacillus anthracis) in all its forms, including cutaneous and inhalation anthrax (postexposure) in adults and children...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week